Literature DB >> 30012296

Alternative and Adjunctive Treatments for Dupuytren Disease.

Paul M N Werker1, Ilse Degreef2.   

Abstract

Clinicians struggle with limited efficacy and durability of standard treatments when treating patients with Dupuytren disease diathesis. Alternative treatments such as low-dose radiation therapy in early phase of disease, supplemental pharmacotherapy with anti-inflammatory and/or anti-mitotic drugs, as well as other pharmacologic targets, and more aggressive surgery such as dermofasciectomy all have been reported with variable success or with serious side effects that hamper their standard use. This article gives an overview of the available literature.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dermofasciectomy; Dupuytren; Firebreak skin graft; Pharmacotherapy; Radiotherapy

Mesh:

Substances:

Year:  2018        PMID: 30012296     DOI: 10.1016/j.hcl.2018.03.005

Source DB:  PubMed          Journal:  Hand Clin        ISSN: 0749-0712            Impact factor:   1.907


  3 in total

1.  Could coenzyme Q10 be the treatment for Dupuytren's disease?

Authors:  Wilma Lourens
Journal:  BMJ Case Rep       Date:  2019-03-01

2.  Echogenicity of Dupuytren's nodules is correlated to myofibroblast load and nodule hardness.

Authors:  Sanne Molenkamp; Whangzao Song; Marjolein Bloembergen; Dieuwke C Broekstra; Paul M N Werker
Journal:  J Hand Surg Eur Vol       Date:  2021-10-07

3.  Focused electromagnetic high-energetic extracorporeal shockwave (ESWT) reduces pain levels in the nodular state of Dupuytren's disease-a randomized controlled trial (DupuyShock).

Authors:  Karsten Knobloch; Marie Hellweg; Heiko Sorg; Tomas Nedelka
Journal:  Lasers Med Sci       Date:  2021-01-23       Impact factor: 3.161

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.